Pharma Business International | The voice of the Pharma industry

MANUFACTURING

Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop digital twin of CAR-T manufacturing

4th December 2024

A new Researcher-in-Residence partnership between the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...

APPROVALS

Novartis’ Kisqali receives European Commission approval in early breast cancer

APPROVALS

European Commission approves BeiGene’s TEVIMBRA for first-line treatment of advanced/metastatic esophageal squamous cell carcinoma and gastric or gastroesophageal junction cancer

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Beckman Coulter and Scopio Labs add world’s first digital bone marrow imaging and analysis to long-term partnership

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of...

DOL Finder platform launch enables users to identify and monitor most influential digital healthcare professionals active in key disease spaces

A UK and US based digital insights consultancy has launched a new platform, DOL Finder, that enables users to identify the most influential healthcare...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

ProductLife Group strengthens global drug development capabilities with acquisition of IntiQuan

ProductLife Group (PLG), a regulatory, scientific, compliance, and digital transformation consulting services firm for the life sciences industry, has acquired IntiQuan, a Swiss boutique...

Astoriom expands biorepository services with new acquisition

Astoriom, a leader in the R&D Sample Stability and Biorepository Storage industry, has acquired the biorepository business of Flagship Biosciences as it strategically expands within the...

Approvals

Novartis’ Kisqali receives European Commission approval in early breast cancer

The European Commission (EC) has approved Novartis' Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of patients with hormone...

European Commission approves BeiGene’s TEVIMBRA for first-line treatment of advanced/metastatic esophageal squamous cell carcinoma and gastric or gastroesophageal junction cancer

The European Commission has approved BeiGene's TEVIMBRA (tislelizumab) in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma (ESCC) and gastric...

U.S. FDA approves Shorla Oncology’s IMKELDI oral solution for certain forms of leukemia and other cancers

Attruby, a near complete TTR stabilizer (≥90%), approved by FDA to reduce cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients

Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease in Japan

European Commission approves Pfizer’s HYMPAVZI for adults and adolescents with severe hemophilia A or B without inhibitors

Manufacturiung

MANUFACTURING

Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop digital twin of CAR-T manufacturing

A new Researcher-in-Residence partnership between the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of...

Process filter maker creates new global pharma and healthcare role

GSK to make up to $800m manufacturing investment in Pennsylvania

FibroBiologics and Charles River collaborate to manufacture fibroblast cell-based therapies for chronic diseases

£4.5m project launched to tackle acute skills shortage in UK medicines manufacturing

New $4.5bn Lilly site to drive innovation in drug production and make medicines for clinical trials

Finance

CBC Group completes acquisition of UCB’s mature neurology and allergy business in China

Roche to acquire Poseida Therapeutics

Northern Gritstone leads £4m Seed investment into single-molecule platform company Exciting Instruments

Novartis acquires Kate Therapeutics

Research & Development
Latest

R&D

Arrowhead forms agreement with Sarepta for multiple clinical and preclinical programs in rare genetic diseases

2nd December 2024

Arrowhead Pharmaceuticals and Sarepta Therapeutics have formed a global licensing and collaboration agreement. The agreement covers multiple clinical and preclinical programs in rare, genetic diseases...

R&D

GSK to acquire CMG1A46 from Chimagen Biosciences, expanding immunology pipeline

31st October 2024

GSK and Chimagen Biosciences have announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager (TCE), from Chimagen...

R&D

Dyno Therapeutics forms partnership with Roche to advance AAV gene therapy vectors for neurological diseases

30th October 2024

Dyno Therapeutics, a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, has announced its second research collaboration with Roche...

R&D

ViaNautis Bio signs agreement with Lilly to develop novel products delivering genetic medicines

29th October 2024

ViaNautis Bio, a biotechnology company at the forefront of delivering targeted genetic nanomedicines, has announced a collaboration with Eli Lilly and Company. Under the terms...

R&D

AbbVie and Gedeon Richter to discover and develop novel targets for neuropsychiatric conditions

25th October 2024

AbbVie and Gedeon Richter have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. This...